法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·UK legislation / curated by LawPlayer from legislation.gov.uk

Statutory Instrument

The Medicines for Human Use (Marketing Authorisation Etc.) Amendment Regulations 1998

Citation
S.I. 1998/3105
As at
Sections
5
Section 1Citation, commencement and interpretation

(1) These Regulations may be cited as the Medicines for Human Use (Marketing Authorisation Etc.) Amendment Regulations 1998 and shall come into force on 1st January 1999.

(2) In these Regulations, “the principal Regulations ” means the Medicines for Human Use (Marketing Authorisation Etc.) Regulations 1994 .

Section 2Amendment of regulation 11 of the principal Regulations

In regulation 11 of the principal Regulations (other Schedules to have effect), after the words “Schedule 5 (labels),”, there shall be inserted the words “Schedule 5A (package leaflets),”.

Section 3Amendment of Schedule 5 to the principal Regulations

(1) After paragraph 5(1)(e) of Schedule 5 to the principal Regulations (labels—relevant medicinal products on a general sale list), there shall be added the following—

(f) if the product contains paracetamol, unless it is wholly or mainly intended for children who are twelve years old or younger, the words “Do not take with any other paracetamol—con taining products”, and

(i) if a package leaflet accompanying the product displays the words set out in quotation marks in paragraph 1 of Schedule 5A, the words “Immediate medical advice should be sought in the case of an overdose, even if you feel well”, or

(ii) if no package leaflet accompanies the product or the package leaflet does not display the words in paragraph 1 of Schedule 5A, the words “Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage”;

(g) if the product contains paracetamol and is wholly or mainly intended for children who are twelve years old or younger, the words “Do not give with any other paracetamol—containing products”; and

(i) if a package leaflet accompanying the product displays the words set out in quotation marks in paragraph 2 of Schedule 5A, the words “Immediate medical advice should be sought in the case of an overdose, even if the child seems well”, or

(ii) if no package leaflet accompanies the product or the package leaflet does not display the words in paragraph 2 of Schedule 5A, the words “Immediate medical advice should be sought in the event of an overdose, even if the child seems well, because of the risk of delayed, serious liver damage”.

(2) In paragraph 5(2)(b) of Schedule 5 to the principal Regulations (labels—relevant medicinal products on a general sale list), after the words “of those sub-paragraphs” there shall be inserted the words “or sub-paragraph (1)(f) or (g)”.

Section 4Insertion of Schedule 5A to the principal Regulations

After Schedule 5 to the principal Regulations (labels), there shall be inserted the following Schedule—

LEAFLETS

(1) Where in accordance with the relevant Community provisions a package leaflet is included in the packaging of a relevant medicinal product containing paracetamol, unless the product is wholly or mainly intended for children who are twelve years old or younger the leaflet shall display the words “Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage”.

(2) Where in accordance with the relevant Community provisions a package leaflet is included in the packaging of a relevant medicinal product containing paracetamol and the product is wholly or mainly intended for children who are twelve years old or younger, the leaflet shall display the words “Immediate medical advice should be sought in the event of an overdose, even if the child seems well, because of the risk of delayed, serious liver damage”.

Section 5Amendment of Schedule 3 to the principal Regulations

(1) In paragraph 11 of Schedule 3 to the principal Regulations, after the words “or of Schedule 5”, there shall be inserted the words “or 5A”.

(2) In paragraph 12 of Schedule 3 to the principal Regulations, after the words “or of Schedule 5”, there shall be inserted the words “or 5A”.

5 sections

Cite this legislation

The Medicines for Human Use (Marketing Authorisation Etc.) Amendment Regulations 1998 (legislation.gov.uk, OGL v3.0). Retrieved via LawPlayer, https://lawplayer.com/uk/act/uksi-1998-3105

Contains public sector information licensed under the Open Government Licence v3.0.

OGL-3

本頁資料來源:legislation.gov.uk (The National Archives)·整理提供:法律人 LawPlayer· lawplayer.com